Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Common Equity (2016 - 2025)

INVO Fertility has reported Common Equity over the past 16 years, most recently at $5.8 million for Q3 2025.

  • Quarterly Common Equity rose 25184.59% to $5.8 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $5.8 million through Sep 2025, up 25184.59% year-over-year, with the annual reading at $12.7 million for FY2024, 1327.77% up from the prior year.
  • Common Equity was $5.8 million for Q3 2025 at INVO Fertility, up from $2.6 million in the prior quarter.
  • Over five years, Common Equity peaked at $12.7 million in Q4 2024 and troughed at -$1.7 million in Q2 2023.
  • The 5-year median for Common Equity is $2.4 million (2021), against an average of $2.9 million.
  • Year-over-year, Common Equity tumbled 150.81% in 2023 and then surged 32744.56% in 2025.
  • A 5-year view of Common Equity shows it stood at $7.3 million in 2021, then tumbled by 113.37% to -$977612.0 in 2022, then surged by 191.33% to $892825.0 in 2023, then skyrocketed by 1327.77% to $12.7 million in 2024, then crashed by 54.12% to $5.8 million in 2025.
  • Per Business Quant, the three most recent readings for IVF's Common Equity are $5.8 million (Q3 2025), $2.6 million (Q2 2025), and $3.3 million (Q1 2025).